Control of scarring in adult wounds using antisense transforming growth factor-β1 oligodeoxynucleotides

Immunology and Cell Biology

Volumn 74, Issue 2, 1996, Pages 144-150

  Choi, Byung Min ^a   Kwak, Hyun Jeong ^a   Jun, Chang Duk ^a   Park, Seok Don ^a   Kim, Ki Young ^a   Kim, Hyung Ryun ^a   Chung, Hun Taeg ^a,b  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

Antisense oligodeoxynucleotides; TGF 1; Wound healing

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FIBROSIS; HISTOPATHOLOGY; MOUSE; NONHUMAN; SCAR FORMATION; WOUND HEALING;

ANIMALIA;

EID: 0029901459     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1996.19     Document Type: Article

References (35)

1. Wahl SM. Transforming growth factor beta (TGF-β) in inflammation: A cause and a cure. J. Clin. Immunol. 1992; 12: 61-74.
2. Barrandon Y, Green H. Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-α and epidermal growth factor. Cell 1987; 50: 1131-7.
3. Ignotz RA, Massage J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337-45.
4. Whitby DJ, Ferguson MWJ. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991a; 112: 651-68.
5. Whibty DJ, Ferguson MWJ. Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol. 1991b; 147: 207-15.
6. Thomas FD, Kawahara R.S. Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Annu. Rev. Med. 1991; 42: 567-84.
7. Associan RK, Sporn MB. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell Biol. 1986; 102: 1217-23.
8. Daniela Q Jr, Nanney LB, Diteshein JA, Davidson JM. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: Incisional wound model. J. Invest. Dermatol. 1991; 97: 34-42.
9. Kovasc EJ. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol. Today 1991; 12: 17-23.
10. Border WA, Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 1992; 90: 1-7.
11. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993; 122: 103-11.
12. Shah M, Foreman DM, Ferguson NWJ. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor β. Lancet 1992; 339: 213-14.
13. Jamall IS, Fimelli VN, Quehee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem. 1981; 112: 70-5.
14. Narumi S, Finke JH, Hamilton TA. Interferon-γ and interleukin-2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem. 1990; 265: 7036-41.
15. Lindholm D, Heumann R, Hengerer B, Thoenen H. Interleukin-1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J. Biol. Chem. 1988; 263: 16 348-51.
16. Auffray C, Rougenon F. Purification of mouse immunoglobin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biol. 1980; 107: 303-14.
17. Chingwin JM, Pryzbyla RJ, Macdonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-8.
18. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping. Science 1988; 241: 708-12.
19. Sadatoshi B, Fu YM, Yu ZX, Stephen EE. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl Acad. Sci. USA 1993; 90: 654-8.
20. Bennett MR, Anglin S, Meewan JR, Jagoe R, Newby AC, Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J. Clin. Invest. 1994; 93: 820-8.
21. Woolf TM, Melton DA, Jennings CGB. Specificity of antisense oligonucleotides in vivo. Proc. Natl Acad. Sci. USA 1992; 89: 7305-9.
22. Thierry AR, Rahman A, Dritschilo A. Liposomal delivery as a new approach to transport antisense oligonucleotides. In: Erickson R, Izant JF (eds) Gene regulation: Biology of antisense RNA and DNA. New York: Raven Press Ltd, 1992; pp. 147-61.
23. Eckstein F. Investigation of enzyme mechanisms with nucleotide phosphorothioates. Annu. Rev. Biochem. 1985; 54: 367-402.
24. Wahl SM, Hunt DA, Wakefield LM et al. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc. Natl Acad. Sci. USA 1987; 84: 5788-92.
25. Hockel M, Sasse J, Wissler JH. Purified monocyte-derived angiogenic substance (Angiotropin) stimulates migration, phenotypic changes, and 'tube formation' but not proliferation of capillary endothelial cells in vitro. J. Cell Physiol. 1987; 133: 1-13.
26. Muller G, Beherns J, Nussbaumer U, Bohlen P, Birchmeier W. Inhibitory action of transforming growth factor beta on endothelial cells. Proc. Natl Acad. Sci. USA 1987; 84: 5600-4.
27. Pierce GF, Mustoe TA, Lingellbach J et al. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J. Cell Biol. 1989a; 109: 429-40.
28. Wahl SM, McCartney-Francis N, Mergenhagen SE. Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today 1989; 10: 258-61.
29. Van Obberghen-Schilling E, Roche NS, Flanders KL, Sporn MB, Robers AB. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 1988; 263: 7741-6.
30. Keski-oja J, Raghow R, Sawday M et al. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin and type 1 procollagen by transforming growth factor-β. J. Biol. Chem. 1988; 263: 3111-15.
31. Pierce GF, Mustoe TA, Lingellbach J, Masakowski VR, Gramates P, Deuel TF. Transforming growth factor β reverses the glucocorticoid induced wound healing deficit in rats. Proc. Natl Acad. Sci. USA 1989b; 86: 2229-33.
32. Hashiro M, Matsumoto K, Okumura H, Hashimoto K, Yoshikawa K. Growth inhibition of human keratinocytes by antisense C-myc oligomer is not coupled to induction of differentation. Biochem. Biophys. Res. Commun. 1991; 174: 287-92.
33. Arsura M, Introna M, Passerini F, Mantovani A, Golay J. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood 1992; 79: 2708-16.
34. Biro S, Fu YM, Yu ZX, Epstein SE. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc. Natl Acad. Sci. USA 1993; 90: 654-8.
35. Jun CD, Choic BM, Kim SU, Lee SY, Kim HM, Chung HT. Down-regulation of transforming growth factor-b gene expression by antisense oligodeoxynucleotides increases recombinant interferon-g-induced nitric oxide synthesis in murine peritoneal macrophages. Immunology 1995; 85: 114-19.